Oric Pharmaceuticals (ORIC) Long-Term Investments (2021 - 2026)

Oric Pharmaceuticals' Long-Term Investments history runs 6 years deep, the most recent figure standing at $137.8 million for Q1 2026.

• Quarterly Long-Term Investments rose 587.55% year-over-year to $137.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $137.8 million (up 587.55% YoY) and the FY2025 annual result came in at $110.8 million, changed N/A from the prior year.
• Long-Term Investments was $137.8 million for Q1 2026 at Oric Pharmaceuticals, up from $110.8 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $137.8 million in Q1 2026 and bottomed at $9.6 million in Q2 2023.
• A 5-year average of $40.6 million and a median of $22.0 million in 2022 frame the typical range for Long-Term Investments.
• Annual changes were most pronounced in 2024 — Long-Term Investments plunged 65.37% — and 2025, when it jumped 1159.33%.
• Oric Pharmaceuticals' Long-Term Investments stood at $22.0 million in 2022, then rose by 22.33% to $26.9 million in 2023, then slumped by 62.77% to $10.0 million in 2024, then surged by 1007.84% to $110.8 million in 2025, then increased by 24.39% to $137.8 million in 2026.
• Business Quant data shows ORIC's Long-Term Investments at $137.8 million in Q1 2026, $110.8 million in Q4 2025, and $125.9 million in Q3 2025.